Is a Hypercoagulable State Present in Hypothyroidism?

• References

• 1 Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgrad Med J 1990; 66: 280-284
• 2 Vanhaelst L, Neve P, Chailly P, Bastenie PA. Coronary artery disease in hypothyroidism. Observations in clinical myxoedema. Lancet 1967; II: 800-802
• 3 Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management and the role of coronary artery bypass surgery. Endocr Rev 1985; 6 (03) 432-440
• 4 Nossel HL, Yudelman I, Canfield RE, Butler jr VP, Spandonis K, Wilner GD. Measurements of Fibrinopeptide A in human blood. J Clin Invest 1974; 54: 43-53
• 5 Kudrick B, Robinson D, Netre C, Hessel B, Blomback B. Measurement in human blood of fibrinogen/fibrin fragments containing the Bp 15-42 sequence. Thromb Res 1982; 25: 277-291
• 6 Bauer KA, Rosemberg RD. The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of haemostatic system activation. Blood 1987; 70 (02) 343-350
• 7 Kochum C, Frebelius S. Rapid radioimmunoassay of human fibrinopeptide A. Removal of cross-reacting fibrinogen with bentonite. Thromb Res 1980; 19: 589-598
• 8 Hume R. Fibrinolytic activity and thyroid function. Br Med J 1965; 1: 686-688
• 9 Bennett NB, Ogston CM, Me Andrew GM. The thyroid and fibrinolysis. Br Med J 1967; 4: 147-148
• 10 Rennie JAN, Bewsher PD, Murchison LE, Ogston D. Coagulation and fibrinolysis in thryroid disease. Acta Haematol 1978; 59: 171-177
• 11 Nossel HL. Relative proteolysis of the fibrinogen Bp chain by thrombin and plasmin as a determinant of thrombosis. Nature 1981; 291: 165-166